ArticleScientific data2026
A single-nucleus RNA-seq dataset of the colon in Pink1-deficient and wild-type mice.
Article in Scientific data, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
PTEN-induced kinase 1 (Pink1), a familial Parkinson's associated gene, is a key regulator of mitochondrial and cellular energy homeostasis. Mutations in Pink1 disrupt mitophagy and perturbations in gastrointestinal homeostasis. This suggests the possibility that Pink1 deficiency may influence neurodegenerative processes by altering gut-to-brain signaling mechanisms. To facilitate investigation of gut-specific consequences of Pink1 deficiency, we generated a single-nucleus RNA sequencing (snRNA-seq) dataset from gut tissue of wild-type (WT) and Pink1 knockout (KO) mice. We identified major cell populations such as goblet cells, immune cells, and colonocytes, and characterized their transcriptional profiles. For technical validation, we utilized a publicly available murine gut (snRNA-seq) dataset. We then applied anchor-based label transfer and confirmed cell-type assignments via random forest classification. This rigorously validated dataset provides a robust resource for exploring shifts in cell-type composition and transcriptional alterations associated with Pink1 loss.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.